Baiyunshan Jinge Blue Lips Twice-born Project restarted

2019-05-16 14:28:21 GPHL GPHL

On May 11th, the launch ceremony for the second Baiyunshan Jinge Blue Lips Twice-born Project was held in Guangzhou.

In attendance were Academician Zhong Nanshan, Joe G. N. Garcia from the American Academy of Science, Principal Wang Xinhua of Guangzhou Medical University and more than one hundred other medical experts in the field of pulmonary vascular disease from around the globe. During the ceremony, GPHL made a donation of a batch of Jinge Sildenafil Citrate Tablets by Baiyunshan Jinge (with a worth of no less than 1.26 million yuan), which would help more patients with pulmonary hypertension (PH) regain health.

Academician Zhong Nanshan

This ‘loving care’ activity was jointly initiated by Baiyunshan Pharmaceutical General Factory and Beijing iSEEK PH Hope Center in 2017. The project has reduced the financial strain on more than 300 PH patients.

Pulmonary hypertension is a kind of pulmonary vascular disease that can potentially lead to cardiac and respiratory failure as the blood pressure in the patient’s lungs arteries constantly elevates. Although PH patients look healthy, they have serious difficulty during physical exertion. Daily activities such as climbing stairs can put their bodies under considerable strain, with PH patients’ lips turning blue due to a lack of oxygen(anoxia), hence the moniker ‘Blue Lips’.

Li Chuyuan, the chairman of GPHL

Jinge Sildenafil Citrate Tablets are the first domestically produced generic drug in this field, and were first put on the market in October, 2014. Through strict clinical and bioequivalence trials, the product has been proven as effective. With guaranteed curative effects and marketing at a reasonable price, it will facilitate the wide spread of PH treatment.

When hearing the brand name Jinge, many people will think of ‘Chinese Viagra’. This product, launched to treat erectile dysfunction (ED), thanks to its good quality and affordable pricing, has achieved remarkable sales since going on the market. However, most people are not aware that besides erectile dysfunction, it can also be used to treat other diseases including PH.

Pei Zejian, Deputy Director of Grand Southern TCM Business of GPHL

According to Academician Zhong Nanshan, sildenafil citrate has been proven to effectively relieve the symptoms of PH in both research and clinical trials. He pointed out that a 25 ml dose of the tablets would treat the disease, tremendously lowering the cost for patients.

Over recent years, Baiyunshan Pharmaceutical General Factory has been working with the team led by Academician Zhong Nanshan on promoting the clinical application of Jinge.

Li Chuyuan, the chairman of GPHL, said that the organisation would extend the scope of Baiyunshan Jinge public welfare programs, benefiting PH patients and their families and hopefully bringing about a ‘Jinge miracle’ assisting in the realisation of a Healthy China cause.

Translated by Ma Xiaojia

Edited by Simon Haywood, Monica Liu

NULL